GEMSTONE⁃301:同步/序贯放化疗后舒格利单抗巩固治疗可提高不可手术的Ⅲ期非小细胞肺癌患者的生存

摘要

1文献来源Wu Y,Zhou Q,Chen M,et al.LBA43⁃GEMSTONE⁃301:A randomized,double⁃blind,placebo⁃controlled,phase 3 study of sugemalimab in patients with unresectable stageⅢnon⁃small cell lung cancer(NSCLC)who had not progressed after concurrent or sequential chemoradiotherapy(CRT)[J].Ann Oncol,2021,32(5S):S1283-S1346。